TUBERCULOSIS

More documents

Recommendations

Info

:: Contents Abbreviations Acknowledgements Executive summary 1 Chapter 1. Introduction 5 Chapter 2. A new era of global TB monitoring 6 Chapter 3. TB disease burden 15 Chapter 4. Diagnosis and treatment: TB, HIV-associated TB and drug-resistant TB 54 Chapter 5. TB prevention services 82 Chapter 6. Universal health coverage, social protection and addressing social determinants: Implications for TB 90 Chapter 7. TB financing 108 Chapter 8. TB research and development 122 iv v Annexes 1. Access to the WHO global TB database 131 2. Country profiles for 30 high TB burden countries 137 3. Regional profiles for 6 WHO regions 171 4. TB burden estimates, notifications and treatment outcomes for individual countries and territories, WHO regions and the world 179 GLOBAL <strong>TUBERCULOSIS</strong> REPORT 2016 :: iii
:: Abbreviations aDSM AE AIDS ART ATP BCG BRICS CC CFR CHOICE CI CRS DST EQA FIND GAF GDP GHE GIS Global Fund GTB HBC HIV IGRA IHME LAMP LPA LTBI MDG MDR active TB drug-safety monitoring and management adverse event acquired immunodeficiency syndrome antiretroviral therapy adenosine triphosphate Bacille-Calmette-Guérin Brazil, the Russian Federation, India, China, South Africa critical concentration case fatality ratio CHOosing Interventions that are Cost- Effective (WHO) confidence interval creditor reporting system drug susceptibility testing external quality assessment Foundation for Innovative New Diagnostics Global Action Framework for TB Research gross domestic product government health expenditures geographic information system The Global Fund to Fight AIDS, TB and Malaria Global TB Programme high burden country human immune-deficiency virus interferon gamma release assays Institute of Health Metrics and Evaluation loop-mediated isothermal amplification line probe assay latent TB infection Millennium Development Goal multidrug-resistant MDR/RR-TB RR-TB cases including MDR-TB cases M:F MSF NGO male to female (ratio) Médecins Sans Frontières nongovernmental organization NHI NTP OBR OECD OOP PAF PMDT POC P:N PPM RR SAE SDG SHA SNP SRL SSI STD TB TBTC TBVI TDR TNF TST UCS UHC UN UNAIDS US USAID VR WHO WRD XDR-TB national health insurance national TB programme optimized background regimen Organisation for Economic Co-operation and Development out-of-pocket population attributable fraction programmatic management of drugresistant TB point-of-care prevalence to notification (ratio) public–private mix rifampicin-resistant serious adverse event Sustainable Development Goal System of health accounts single nucleotide polymorphism Supranational Reference Laboratory Statens Serum Institute sexually transmitted disease tuberculosis TB Trial Consortium Tuberculosis Vaccine Initiative Special Programme for Research and Training in Tropical Diseases tumour necrosis factor tuberculin skin test Universal Coverage Scheme (Viet Nam) universal health coverage United Nations Joint United Nations Programme on HIV/ AIDS United States US Agency for International Development vital registration World Health Organization WHO-recommended rapid diagnostic extensively drug-resistant TB iv :: GLOBAL <strong>TUBERCULOSIS</strong> REPORT 2016
Page 1 and 2: GLOBAL REPORT TUBERCULOSIS 2016
Page 3: WHO Library Cataloguing-in-Publicat
Page 7 and 8: The principal source of financial s
Page 9: Zhumagali Ismailov, Sarah Jackson,
Page 12 and 13: :: Executive Summary Background The
Page 14 and 15: TB prevention services South Africa
Page 16 and 17: Chapter 1 :: Introduction Tuberculo
Page 18 and 19: :: Box 2.1 The Sustainable Developm
Page 20 and 21: :: Box 2.3 The End TB Strategy at a
Page 22 and 23: :: TABLE 2.1 Top 10 indicators (not
Page 24 and 25: TABLE 2.2 :: The three TB high-burd
Page 26 and 27: Chapter 3 :: TB disease burden :: K
Page 28 and 29: :: Box 3.1 The WHO Global Task Forc
Page 30 and 31: :: Box 3.2 Updates to estimates of
Page 32 and 33: :: Box 3.3 Updated and interim esti
Page 34 and 35: :: FIG. 3.1 Strengthening national
Page 36 and 37: :: TABLE 3.2 Estimated epidemiologi
Page 38 and 39: :: FIG. 3.3 Estimated TB incidence
Page 40 and 41: :: FIG. 3.5 Global trends in the es
Page 42 and 43: :: FIG. 3.8 Trends in estimated TB
Page 44 and 45: :: FIG. 3.10a Top causes of death w
Page 46 and 47: :: FIG. 3.14 Trends in estimated TB
Page 48 and 49: :: FIG. 3.16 Data sources available
Page 50 and 51: :: TABLE 3.5 Estimated incidence of
Page 52 and 53: :: FIG. 3.20 Estimated incidence of
Page 54 and 55:
:: FIG. 3.22 Global progress in imp
Page 56 and 57:
:: TABLE 3.6 Number of TB cases fou
Page 58 and 59:
:: TABLE 3.7 HIV-negative and HIV-p
Page 60 and 61:
:: FIG. 3.29a The prevalence:notifi
Page 62 and 63:
:: FIG. 3.31b The average CFR by st
Page 64 and 65:
SIM and SINAN case-based databases,
Page 66 and 67:
Prompt and accurate diagnosis of tu
Page 68 and 69:
:: FIG. 4.2 New and relapse TB case
Page 70 and 71:
:: FIG. 4.5 Percentage of new and r
Page 72 and 73:
:: FIG. 4.8 Global numbers of notif
Page 74 and 75:
:: TABLE 4.4 National guidance in p
Page 76 and 77:
:: FIG. 4.9 Percentage of bacteriol
Page 78 and 79:
:: FIG. 4.12 Number of MDR/RR-TB ca
Page 80 and 81:
:: FIG. 4.14 Case notification rate
Page 82 and 83:
:: FIG. 4.16a The ten countries wit
Page 84 and 85:
:: Box 4.5 Community contributions
Page 86 and 87:
:: FIG. 4.18 Estimated ART treatmen
Page 88 and 89:
issued in March 2013 and updated in
Page 90 and 91:
:: FIG. 4.22 Treatment outcomes for
Page 92 and 93:
:: Box 4.6 Active TB drug-safety mo
Page 94 and 95:
Prevention of new infections of Myc
Page 96 and 97:
:: TABLE 5.2 TB preventive treatmen
Page 98 and 99:
:: TABLE 5.3 Provision of TB preven
Page 100 and 101:
:: FIG. 5.5 Coverage of BCG vaccina
Page 102 and 103:
This chapter aims to provide a tube
Page 104 and 105:
:: FIG. 6.2 Government spending on
Page 106 and 107:
:: Box 6.1 Implications for TB of e
Page 108 and 109:
:: Box 6.2 Innovations in engaging
Page 110 and 111:
:: Box 6.4 Reforming systems to exp
Page 112 and 113:
:: TABLE 6.1 TB patient social supp
Page 114 and 115:
:: FIG. 6.5 Surveys of costs faced
Page 116 and 117:
:: TABLE 6.3 Status of selected SDG
Page 118 and 119:
Continue current trend (base case s
Page 120 and 121:
can provide insights into progress
Page 122 and 123:
lion, most (US$ 4.4 billion, 67%) i
Page 124 and 125:
:: Box 3.2 Updates to estimates of
Page 126 and 127:
:: FIG. 7.5 Funding for NTP budgets
Page 128 and 129:
:: Box 7.2 International donor fund
Page 130 and 131:
:: FIG. 7.6 Reported funding gaps f
Page 132 and 133:
:: Box 7.3 Methods used to estimate
Page 134 and 135:
:: Box 8.1 WHO’s Global Action Fr
Page 136 and 137:
is critical to allow for the time-s
Page 138 and 139:
:: FIG. 8.2 The global development
Page 140 and 141:
:: FIG. 8.3 The development pipelin
Page 142:
Annex 1 Access to the WHO global TB
Page 145 and 146:
A data dictionary that defines each
Page 147:
Annex 2 Country profiles :: FOR 30
Page 150 and 151:
Bangladesh population 2015 :: 161 m
Page 152 and 153:
China population 2015 :: 1 376 mill
Page 154 and 155:
Democratic Republic of the Congo po
Page 156 and 157:
India population 2015 :: 1 311 mill
Page 158 and 159:
Kenya population 2015 :: 46 million
Page 160 and 161:
Myanmar population 2015 :: 54 milli
Page 162 and 163:
Pakistan population 2015 :: 189 mil
Page 164 and 165:
Russian Federation population 2015
Page 166 and 167:
Thailand population 2015 :: 68 mill
Page 168:
Viet Nam population 2015 :: 93 mill
Page 171 and 172:
Central African Republic population
Page 173 and 174:
Lesotho population 2015 :: 2.1 mill
Page 175 and 176:
Namibia population 2015 :: 2.5 mill
Page 177 and 178:
Sierra Leone population 2015 :: 6.5
Page 179 and 180:
Zimbabwe population 2015 :: 16 mill
Page 182 and 183:
WHO African Region WHO MEMBER STATE
Page 184 and 185:
WHO Eastern Mediterranean Region WH
Page 186 and 187:
WHO South-East Asia Region WHO MEMB
Page 188:
Annex 4 TB burden estimates, notifi
Page 191 and 192:
:: TABLE A4.1 TB incidence estimate
Page 193 and 194:
:: TABLE A4.1 Table TB incidence A4
Page 195 and 196:
:: Table TABLE A4.2 A4.2 Estimates
Page 197 and 198:
Table :: TABLE A4.2 A4.2 Estimates
Page 199 and 200:
:: TABLE A4.3 Measured percentage o
Page 201 and 202:
:: TABLE A4.3 Measured Table A4.3 p
Page 203 and 204:
:: TABLE A4.4 TB case notifications
Page 205 and 206:
:: TABLE A4.4 TB case notifications
Page 207 and 208:
:: TABLE A4.5 Treatment outcomes by
Page 209 and 210:
:: TABLE A4.5 Treatment outcomes by
Page 211:
ISBN 9 789241 565394 Ending TB by 2
show all

TUBERCULOSIS

Create successful ePaper yourself

Delete template?

Save as template?